Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Omega-3 supplement aims to raise key blood fats for heart and brain health

NCT ID NCT07753174

Disease control Sponsor: Revive Active Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This 12-week trial is testing whether a daily omega-3 supplement, called Omega Active, can increase blood levels of DHA and EPA—two fatty acids linked to heart and cognitive health. Healthy adults aged 18-65 will take two capsules daily and provide blood samples at the start and end of the study. Participants will also report any changes in their thinking, digestion, and overall well-being through questionnaires. The study aims to see if the supplement can effectively raise these important fats in the body.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Omega Active supplement (omega-3 fatty acids)
What this could lead to
If successful, this could support the use of omega-3 supplements to improve blood levels of DHA and EPA, which are important for heart and brain health.
What could go wrong
This is a small, single-arm study without a placebo group, so results may not prove cause and effect. Also, self-reported outcomes are subjective and may not reflect objective benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 49 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be male or female. * Be aged 18-65. * Anyone in good general health. * Willing to avoid taking other supplements, prescription medications, or herbal remedies that target DHA or EPA levels in the body, for the duration of the study. * Must not have taken fish oil or plant-based omega oil supplements in the past eight weeks. * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. * Resides in the United States. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Anyone on anticoagulants or antiplatelet therapy. * Anyone with a bleeding disorder. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). * Anyone unwilling to follow the study protocol. * Anyone who does not consume any specific dietary ingredients for any reason. * Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular health Cognitive health Dha and epa blood levels Omega-3 deficiency

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Citruslabs

    RECRUITING

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.